Jane is responsible for the spread of prostate cancer

Jane is responsible for the spread of prostate cancer

Study suggests rapid surveillance allows it to end deadly activity

Cancer inside the prostate

London: Middle East

NEW YORK (Reuters Health) – A gene specific for prostate cancer tumors is showing signs of predisposition to cancer, researchers at Rutgers University said. Targeting this gene will help prolong the patient's life.
In a study published in the journal Nature Communications, scientists discovered the "NSD2" gene through an algorithm developed to determine the types of genes that contribute to the spread of cancer in mouse models.
Scientists were able to stop the activity of this gene in cancer tumor cells in mice, which resulted in a significant decrease in the spread.
"Now that the patient has been diagnosed with prostate cancer, doctors can determine the course of the disease, but they can not say how it will spread," said Antonina Mitrovanova, assistant professor at the School of Health Professionals of the University and researcher at Rutgers Cancer Institute. "If we knew that the disease could spread at the time of diagnosis, we could treat it at the right time to prevent its spread," she said.
The researchers are currently developing a drug to fight against the "NSD2" gene, but they have asked doctors to introduce a test to quickly detect this gene in the most serious patients.
Although the study focuses on prostate cancer, his methods could also be used to study other cancers, said Mitrovanova.

United Kingdom

Cancer